(Q54290367)

27 May 2018

title

Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer. (English)

1 reference

27 May 2018

1 reference

Li-Sha Ying

1

1 reference

27 May 2018

Jiang-Liu Yu

series ordinal

2

1 reference

27 May 2018

Xiao-Xiao Lu

series ordinal

3

1 reference

27 May 2018

Zhi-Qiang Ling

series ordinal

4

1 reference

27 May 2018

publication date

26 September 2012

1 reference

27 May 2018

Digestive Diseases and Sciences

published in

1 reference

27 May 2018

volume

58

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

414-422

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s10620-012-2381-3

exact match

0 references

cites work

Global patterns of cancer incidence and mortality rates and trends

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Surgical treatment of early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Preoperative and postoperative chemotherapy for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Treatment of resectable gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Drug resistance: challenges to effective therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Systemic therapy for advanced gastric cancer: a clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Recent advances in chemotherapy for advanced gastric cancer in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Heterogeneity of chemosensitivity in esophageal cancer using ATP-tumor chemosensitivity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Using quantitative proteomic analysis to understand genotype specific intrinsic drug resistance in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Cellular chemosensitivity assays: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Overexpression of Reg IV in colorectal adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Reg IV expression and clinicopathologic features of gallbladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Reg IV expression is associated with cell growth and prognosis of adenoid cystic carcinoma in the salivary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Reg IV: a promising marker of hormone refractory metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Reg IV enhances peritoneal metastasis in gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Cell sensitivity assays: the ATP-based tumor chemosensitivity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2381-3

Methods and goals for the use of in vitro and in vivo chemosensitivity testing

21 January 2018

1 reference

12 December 2020

Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer

1 reference

12 December 2020

The role of chemotherapy in metastatic gastric cancer.

1 reference

12 December 2020

[Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer]

1 reference

12 December 2020

Reg IV regulates normal intestinal and colorectal cancer cell susceptibility to radiation-induced apoptosis

1 reference

12 December 2020

Treatment strategies in gastric cancer

1 reference

12 December 2020

Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements

1 reference

12 December 2020

Expression of Reg IV and Hath1 in neuroendocrine neoplasms

1 reference

12 December 2020

Identification of molecular determinants of tumor sensitivity and resistance to anticancer drugs.

1 reference

12 December 2020

REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study

1 reference

12 December 2020

Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker

1 reference

12 December 2020

Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma

1 reference

12 December 2020

Reg IV can serve for early diagnosis and therapy

1 reference

12 December 2020

Retrospective analysis of treatment for advanced gastric cancer with peritoneal dissemination

1 reference

12 December 2020

10.1007/S10620-012-2381-3

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

23010741

1 reference

27 May 2018